AUS
NZ
UK
CA
USA
IND
Highlights
- Strategic Move: (NGI) secures a 23.5% stake in healthcare-focused private equity firm 1315 Capital.
- Investment Structure: USD 70.5 million deal, partially deferred and performance-linked.
- Long-Term Growth: Strengthens (NGI)’s position in private equity with healthcare sector exposure.
Navigator Global Investments (ASX:NGI) has made a strategic expansion move by acquiring a 23.5% equity stake in healthcare investment firm 1315 Capital. The deal, valued at a maximum of USD 70.5 million, reinforces (NGI)’s commitment to diversifying its portfolio within the private equity space.
The transaction will be financed through (NGI)’s existing financial reserves, with USD 27.5 million structured as a deferred payment, contingent on certain performance milestones. Despite this investment, 1315 Capital’s day-to-day operations and decision-making processes will remain independent, ensuring business continuity.
Key Investment Terms and Strategic Alignment
This minority stake includes an interest in certain carried interests, along with protective measures to ensure alignment between both firms. Leveraging a strong financial position, (NGI) has structured the transaction without any disruptions to its core operations.
The move aligns with (NGI)’s long-term strategy of expanding exposure to private equity, particularly within the healthcare sector. Partnering with 1315 Capital provides an opportunity to tap into a specialized segment of the private market that is both fragmented and offers strong potential for value creation. The investment is expected to enhance cash flow as new funds are raised and existing investments mature.
About 1315 Capital and Its Investment Expertise
1315 Capital, a Philadelphia-based private equity firm, focuses exclusively on healthcare investments and has over USD 1 billion in capital commitments. The firm specializes in funding commercial-stage healthcare businesses, including medtech, pharma outsourcing, and healthcare services companies. With a team of 20 professionals, 1315 Capital employs a differentiated investment process designed to drive premium portfolio exits.
The firm’s leadership team includes experienced investors Adele C. Oliva and Michael Koby, who bring over two decades of expertise in healthcare-focused private equity. Their strategic insights and extensive industry connections contribute to the firm’s track record of successful investments.
Expanding Market Position in Healthcare Private Equity
This investment enhances (NGI)’s position within the healthcare-focused private equity market while providing long-term diversification benefits. The partnership with 1315 Capital supports (NGI)’s broader growth strategy by strengthening its earnings profile and expanding its reach in a high-growth sector.
With this move, (NGI) continues to reinforce its strategic vision, aligning with high-potential investment opportunities that offer both stability and growth potential.
